Skip to main content

Table 3 The 2 year estimated OS and PFS rate in different subgroups

From: Clinical and prognostic analysis of 78 patients with human immuno-deficiency virus associated non-Hodgkin’s lymphoma in Chinese population

 

OS (%)

PFS (%)

Ann Arbor stage

 I, II

88.6 ± 6.3

68.6 ± 8.3

 III, IV

13.0 ± 10.3

8.4 ± 6.7

Extranodal diseases

 0, 1

71.7 ± 7.8

54.5 ± 7.4

  > 1

10.3 ± 9.5

0

ECOG score

 0, 1

90.2 ± 6.6

73.9 ± 9.2

  > 1

51.4 ± 9.0

20.1 ± 6.7

IPI score

 0, 1

95.0 ± 4.9

80.4 ± 8.8

  > 1

49.6 ± 8.8

19.9 ± 6.4